Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maaike Schuur

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 7, 2022
[A drug induced deviation of the eyes: the oculogyric crisis]Tim Van Osch, Anne T Kloek, Maaike Schuur, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Human spongiform encephalopathies in the Netherlands]Maaike Schuur, Casper Jansen, Annemieke J M Rozemuller, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands]Casper Jansen, Maaike Schuur, Wim G M Spliet, et al.
European Journal of Epidemiology|February 2, 2013
Distinguishing true from false positives in genomic studies: p valuesLinda Broer, Christina M Lill, Maaike Schuur, et al.
Neurobiology of Aging|October 1, 2011
Plasma β amyloid and the risk of Alzheimer's disease in Down syndromeAntonia M W Coppus, Maaike Schuur, Jeanet Vergeer, et al.
Cancers|March 8, 2020
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic ReviewCyrillo G Brahm, Myra E van Linde, Roelien H Enting, et al.
Neuroscience Letters|January 29, 2010
No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob diseaseSteven J Collins, Maaike Schuur, Alison Boyd, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2015
Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob diseasePeter Maat, Janet W de Beukelaar, Casper Jansen, et al.
Neuro-Oncology Practice|August 15, 2025
Severe temozolomide-induced thrombocytopenia is linked to increased healthcare utilization in glioblastoma and disproportionally impacts female patientsLeon van Hout, Alessia D Borgo, Nienke Grun, et al.
Heliyon|February 17, 2023
Frequency and burden of potentially treatable symptoms in glioma patients with stable diseaseJantine G Röttgering, Vera Belgers, Mathilde C M Kouwenhoven, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nederlands Tijdschrift Voor Geneeskunde|February 7, 2022
[A drug induced deviation of the eyes: the oculogyric crisis]Tim Van Osch, Anne T Kloek, Maaike Schuur, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Human spongiform encephalopathies in the Netherlands]Maaike Schuur, Casper Jansen, Annemieke J M Rozemuller, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands]Casper Jansen, Maaike Schuur, Wim G M Spliet, et al.
European Journal of Epidemiology|February 2, 2013
Distinguishing true from false positives in genomic studies: p valuesLinda Broer, Christina M Lill, Maaike Schuur, et al.
Neurobiology of Aging|October 1, 2011
Plasma β amyloid and the risk of Alzheimer's disease in Down syndromeAntonia M W Coppus, Maaike Schuur, Jeanet Vergeer, et al.
Cancers|March 8, 2020
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic ReviewCyrillo G Brahm, Myra E van Linde, Roelien H Enting, et al.
Neuroscience Letters|January 29, 2010
No evidence for prion protein gene locus multiplication in Creutzfeldt-Jakob diseaseSteven J Collins, Maaike Schuur, Alison Boyd, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 25, 2015
Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob diseasePeter Maat, Janet W de Beukelaar, Casper Jansen, et al.
Neuro-Oncology Practice|August 15, 2025
Severe temozolomide-induced thrombocytopenia is linked to increased healthcare utilization in glioblastoma and disproportionally impacts female patientsLeon van Hout, Alessia D Borgo, Nienke Grun, et al.
Heliyon|February 17, 2023
Frequency and burden of potentially treatable symptoms in glioma patients with stable diseaseJantine G Röttgering, Vera Belgers, Mathilde C M Kouwenhoven, et al.
Pageof 3